Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis
Cancer is a major life-threatening disease with a high mortality rate in many countries. Even though different therapies and options are available, patients generally prefer chemotherapy. However, serious side effects of anti-cancer drugs compel us to search for a safer drug. To achieve this target,...
Main Authors: | Magdi E. A. Zaki, Sami A. Al-Hussain, Syed Nasir Abbas Bukhari, Vijay H. Masand, Mithilesh M. Rathore, Sumer D. Thakur, Vaishali M. Patil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/3/303 |
Similar Items
-
Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
by: Samarpan Maiti, et al.
Published: (2022-08-01) -
Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
by: Syed Nasir Abbas Bukhari, et al.
Published: (2022-07-01) -
Development of machine learning models for the screening of potential HSP90 inhibitors
by: Mohd Imran Khan, et al.
Published: (2022-10-01) -
Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
by: Vijay H. Masand, et al.
Published: (2022-11-01) -
Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations
by: Tihomir Tomašič, et al.
Published: (2020-09-01)